D
Voyager Therapeutics, Inc. VYGR
$3.77 -$0.18-4.56% NASDAQ
Recommendation
Prev Close
$3.95
Volume
650,383
Avg Vol (90D)
703,580
Market Cap
$219.62M
Dividend & Yield
--
52-Week Range
$2.65 - $7.44
P/E (TTM)
--
EPS (TTM)
-$2.17
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Recommendation of "Moderate Buy" from Analysts
12/2/2025 - MarketBeat
Voyager Therapeutics (NASDAQ:VYGR) Shares Pass Below Fifty Day Moving Average - Here's What Happened
11/28/2025 - MarketBeat
Voyager Therapeutics (VYGR, $4.16) entered Downtrend as Momentum indicator drops below 0 level on Nov 19, 2025
11/20/2025 - Tickeron - Stocks
Voyager Therapeutics (VYGR, $4.28) Stochastic Oscillator left the oversold zone on November 18, 2025
11/19/2025 - Tickeron - Stocks
Voyager Therapeutics (VYGR, $4.11) RSI Indicator left the oversold zone on November 17, 2025
11/18/2025 - Tickeron - Stocks
FY2025 Earnings Forecast for VYGR Issued By HC Wainwright
11/17/2025 - MarketBeat
Benign Growth For Voyager Therapeutics, Inc. (NASDAQ:VYGR) Underpins Stock's 26% Plummet
11/15/2025 - Simply Wall St
Research Analysts Offer Predictions for VYGR FY2025 Earnings
11/14/2025 - MarketBeat
VYGR FY2025 EPS Forecast Boosted by Cantor Fitzgerald
11/14/2025 - MarketBeat
What is Wedbush's Estimate for VYGR FY2025 Earnings?
11/14/2025 - MarketBeat
Voyager Therapeutics (VYGR, $3.98) RSI Indicator left the oversold zone on November 13, 2025
11/14/2025 - Tickeron - Stocks
Voyager Therapeutics (VYGR, $3.98) Stochastic Oscillator left the oversold zone on November 13, 2025
11/14/2025 - Tickeron - Stocks
Earnings Update: Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
11/14/2025 - Simply Wall St
HC Wainwright Issues Pessimistic Forecast for Voyager Therapeutics (NASDAQ:VYGR) Stock Price
11/13/2025 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR) and Skye Bioscience (SKYE)
11/12/2025 - TipRanks Financial Blog
Wedbush Reiterates "Outperform" Rating for Voyager Therapeutics (NASDAQ:VYGR)
11/12/2025 - MarketBeat
Voyager Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
11/12/2025 - TipRanks Financial Blog
Voyager Therapeutics price target lowered by $5 at H.C. Wainwright, here's why
11/12/2025 - The Fly
Voyager Therapeutics (VYGR, $4.26) Stochastic Oscillator left the oversold zone on November 11, 2025
11/12/2025 - Tickeron - Stocks
Voyager Therapeutics (NASDAQ:VYGR) Issues Earnings Results, Beats Expectations By $0.06 EPS
11/11/2025 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO), Voyager Therapeutics (VYGR) and Terns Pharmaceuticals (TERN)
11/11/2025 - TipRanks Financial Blog
Wedbush Keeps Their Buy Rating on Voyager Therapeutics (VYGR)
11/11/2025 - TipRanks Financial Blog
Voyager Therapeutics files $400M mixed securities shelf
11/10/2025 - TipRanks Financial Blog
Voyager Therapeutics files $400M mixed securities shelf
11/10/2025 - The Fly
Voyager Therapeutics price target lowered to $11 from $12 at Leerink
11/10/2025 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$31.32M
EBITDA (TTM)
-$133.41M
EBIT (TTM)
-$137.44M
Net Income (TTM)
-$126.78M
Balance Sheet
Total Assets (Q)
$288.31M
Total Debt (Q)
$38.37M
Total Liabilities (Q)
$68.49M
Book Value Per Share (Q)
$3.96
Cash Flow
Cash from Operations (TTM)
-$116.73M
Cash from Investing (TTM)
$50.82M
Cash from Financing (TTM)
$1.25M
Net Change in Cash (TTM)
-$64.66M
Filings
Filing Date
Monday, November 10, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 9 and 13 (est)
Price History
Loading...
Beta
1.40
7-Day Total Return
-7.82%
30-Day Total Return
-25.64%
60-Day Total Return
-11.50%
90-Day Total Return
16.36%
Year to Date Total Return
-36.85%
1-Year Total Return
-45.60%
2-Year Total Return
-49.87%
3-Year Total Return
-41.55%
5-Year Total Return
-52.70%
52-week Low
May 30, 2025 - $2.65
52-week High
Dec 02, 2024 - $7.44
Valuation
Market Cap
$219.62M - Micro Cap
Enterprise Value
$28.98M
Price/Sales (TTM)
7.42
Price/Book (Q)
1.00
Dividends and Shares
Shares Outstanding
58.80
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.voyagertherapeutics.com
Phone Number
857 259 5340
Address
75 Hayden Avenue
Lexington, MA 02421
Country
United States
Year Founded
2013
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. The company’s lead product candidate is VY7523, an anti-tau antibody... more
NASDAQ 12/02/2025 4:00PM Eastern Quotes delayed